Cargando…

Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series

PURPOSE: COVID-19 patients on anti-CD20 treatment can suffer a delayed viral clearance and worse clinical outcome. We aim to present our experience with remdesivir treatment in anti-CD20-treated patients with prolonged symptoms, a patient population for which no data from randomized controlled trial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rüfenacht, Susanne, Gantenbein, Pascal, Boggian, Katia, Flury, Domenica, Kern, Lukas, Dollenmaier, Günter, Kohler, Philipp, Albrich, Werner C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010446/ https://www.ncbi.nlm.nih.gov/pubmed/35426564 http://dx.doi.org/10.1007/s15010-022-01821-y

Ejemplares similares

Characteristics of patients with Coronavirus Disease 2019 (COVID-19) and seasonal influenza at time of hospital admission: a single center comparative study
por: Sieber, Pablo, et al.
Publicado: (2021)

It is complicated: Potential short- and long-term impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance—An expert review
por: Seneghini, Marco, et al.
Publicado: (2022)

Impact of the coronavirus disease 2019 (COVID-19) pandemic on the adherence to hand hygiene practice in hospitals—Data from a Swiss national surveillance system
por: Rüfenacht, Susanne, et al.
Publicado: (2023)

A traveller presenting with severe melioidosis complicated by a pericardial effusion: a case report
por: Schultze, Detlev, et al.
Publicado: (2012)

The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature
por: Thoma, Reto, et al.
Publicado: (2022)

Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study
por: Leal-Neto, Onicio, et al.
Publicado: (2021)

Ward-level risk factors associated with nosocomial coronavirus disease 2019 (COVID-19) outbreaks: A matched case–control study
por: Thoma, Reto, et al.
Publicado: (2022)

Influenza-associated aspergillosis in critically-ill patients—a retrospective bicentric cohort study
por: Waldeck, Frederike, et al.
Publicado: (2020)

Clinical outcomes of adults hospitalized for laboratory confirmed respiratory syncytial virus or influenza virus infection
por: Chorazka, Magdalena, et al.
Publicado: (2021)

Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019
por: Montastruc, François, et al.
Publicado: (2020)

Remdesivir and Mortality in Patients With Coronavirus Disease 2019
por: Diaz, George A, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study
por: Kohler, Philipp P., et al.
Publicado: (2020)

Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection
por: Martinez, Mario A, et al.
Publicado: (2022)

Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018
por: Barnsteiner, Stefanie, et al.
Publicado: (2021)

Remdesivir for coronavirus 2019 (COVID-19): More promising but still unproven
por: Shih, Richard D., et al.
Publicado: (2020)

Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review
por: Yang, Chih-Jen, et al.
Publicado: (2021)

Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019
por: Igbinosa, Irogue, et al.
Publicado: (2020)

Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
por: Burwick, Richard M, et al.
Publicado: (2020)

Remdesivir in Pregnant Patients with Novel Coronavirus Disease 2019: Case Series
por: Singh, Renu, et al.
Publicado: (2021)

Progression of COVID-19 in a Patient on Anti-CD20 Antibody Treatment: Case Report and Literature Review
por: Burgener, Sebastian, et al.
Publicado: (2022)

WITHDRAWN: Remdesivir investigational trials in coronavirus disease 2019: a critical reappraisal()()
por: Brouqui, P., et al.
Publicado: (2020)

Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence
por: Lin, Hui Xian Jaime, et al.
Publicado: (2021)

The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a systematic review
por: Roshanshad, Amirhossein, et al.
Publicado: (2020)

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)
por: Pallotto, Carlo, et al.
Publicado: (2021)

Remdesivir for patients with Coronavirus disease 2019 pneumonia requiring high oxygen support
por: Alibrahim, Rim S., et al.
Publicado: (2022)

Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
por: Touafchia, Anthony, et al.
Publicado: (2021)

Safety of Remdesivir for Patients 80 Years of Age or Older with Coronavirus Disease 2019 (COVID-19)
por: Kanai, Osamu, et al.
Publicado: (2021)

Randomized controlled trials of remdesivir in hospitalized coronavirus disease 2019 patients: A meta-analysis
por: Sarfraz, Azza, et al.
Publicado: (2021)

Remdesivir-Induced Liver Injury in a Patient With Coronavirus Disease 2019 and History of Congestive Hepatopathy
por: Dividis, Georgios P, et al.
Publicado: (2022)

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
por: Olender, Susan A, et al.
Publicado: (2020)

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
por: Wang, Manli, et al.
Publicado: (2020)

Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality
por: Olender, Susan A, et al.
Publicado: (2021)

Remdesivir
por: Bakheit, Ahmed H., et al.
Publicado: (2023)

Safety Evaluation of a Medical Congress Held During the COVID-19 Pandemic—A Prospective Cohort
por: Sumer, Johannes, et al.
Publicado: (2022)

Extracorporeal membrane oxygenation may decrease the plasma concentration of remdesivir in a patient with severe coronavirus disease 2019
por: Ide, Satoshi, et al.
Publicado: (2021)

Remdesivir in pregnant women with moderate to severe coronavirus disease 2019 (COVID-19): a retrospective cohort study
por: Arbabzadeh, Taraneh, et al.
Publicado: (2023)

Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease
por: Cross, Robert W., et al.
Publicado: (2022)

Vascular Endograft Infection with Listeria monocytogenes reated with Surgical Debridement but without Graft Removal
por: Tanner-Steinmann, Beate, et al.
Publicado: (2011)

Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future
por: Schuetz, Philipp, et al.
Publicado: (2011)

Remdesivir in Breastfeeding
por: Sadati, Elham, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hl7vr9nrqqdpghih2e4dd68ksl